Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced non-small cell lung cancer.
Hiroaki Senju
No relevant relationships to disclose
Daiki Ogawara
No relevant relationships to disclose
Yoichi Nakamura
No relevant relationships to disclose
Minoru Fukuda
No relevant relationships to disclose
Katsumi Nakatomi
No relevant relationships to disclose
Hiroshi Gyotoku
No relevant relationships to disclose
Hirofumi Nakano
No relevant relationships to disclose
Hiroyuki Yamaguchi
No relevant relationships to disclose
Nanae Tomonaga
No relevant relationships to disclose
Takaya Ikeda
No relevant relationships to disclose
Kosuke Mizoguchi
No relevant relationships to disclose
Kohei Motoshima
No relevant relationships to disclose
Seiji Doi
No relevant relationships to disclose
Kazuhiro Tsukamoto
No relevant relationships to disclose
Shigeru Kohno
No relevant relationships to disclose